Epilepsia Open

Scope & Guideline

Leading the way in open access epilepsy scholarship.

Introduction

Welcome to the Epilepsia Open information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Epilepsia Open, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherWILEY
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationEPILEPSIA OPEN / Epilepsia Open
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

Epilepsia Open is dedicated to advancing the understanding, diagnosis, and treatment of epilepsy through high-quality research. The journal encompasses a wide range of topics related to epilepsy, including clinical, translational, and basic science studies. It aims to bridge the gap between laboratory research and clinical practice, ensuring that findings contribute to improved patient outcomes.
  1. Clinical Research in Epilepsy:
    The journal publishes studies focusing on the clinical aspects of epilepsy, including treatment efficacy, safety profiles of anti-seizure medications, and surgical interventions. This includes observational studies, clinical trials, and systematic reviews that provide insights into patient management.
  2. Genetic and Molecular Studies:
    Research that investigates the genetic underpinnings of epilepsy, including the identification of pathogenic variants and their implications for treatment. This area emphasizes the integration of genetics into clinical practice, such as genetic testing and personalized medicine approaches.
  3. Neurophysiology and Neuroimaging:
    The journal features studies employing advanced neurophysiological techniques like EEG, SPECT, and MRI to better understand the mechanisms of epilepsy. This includes research on seizure prediction, biomarkers, and the impact of neuroimaging on surgical outcomes.
  4. Psychosocial Aspects of Epilepsy:
    Articles addressing the psychosocial impact of epilepsy on patients and their families, including stigma, mental health comorbidities, and quality of life assessments. This aspect highlights the importance of holistic care in epilepsy management.
  5. Innovative Therapies and Interventions:
    Research on novel therapeutic approaches, including digital health interventions, dietary therapies (like the ketogenic diet), and neuromodulation techniques such as vagus nerve stimulation. This includes both clinical efficacy studies and pilot trials.
The journal has demonstrated a dynamic evolution in its research focus, showcasing several emerging themes that reflect current trends in epilepsy research. These areas are gaining attention and are likely to shape future investigations.
  1. Digital Health and Telemedicine:
    With the rise of digital health technologies, there is an increasing focus on telemedicine and digital interventions for epilepsy management. Studies exploring the effectiveness of mobile apps and online platforms for patient engagement and self-management are becoming more prevalent.
  2. Precision Medicine and Genetic Testing:
    The integration of genetic testing into clinical practice for epilepsy is gaining momentum, with more studies focusing on personalized treatment approaches based on individual genetic profiles. This trend is significant as it aligns with the broader movement towards precision medicine.
  3. Long-term Outcomes and Quality of Life Assessments:
    There is a growing emphasis on long-term outcomes and quality of life in epilepsy patients. Research is increasingly looking at how treatment impacts not just seizure control but also overall well-being and daily functioning.
  4. Comorbidities in Epilepsy:
    Research exploring the relationship between epilepsy and various comorbid conditions, such as psychiatric disorders, cognitive impairment, and metabolic issues, is on the rise. This reflects a holistic approach to understanding the complexities of epilepsy.
  5. Novel Treatment Modalities:
    Emerging therapies, including cannabinoids, neuromodulation techniques, and dietary interventions, are gaining attention. Research is focusing on their efficacy and safety, indicating a shift towards exploring alternative treatment options beyond traditional medications.

Declining or Waning

While the journal covers a broad spectrum of epilepsy research, certain themes appear to be declining in prominence based on recent publications. These waning topics may reflect shifts in research focus or the emergence of new areas of interest.
  1. Historical Perspectives on Epilepsy:
    There has been a noticeable reduction in papers focusing on the historical context and evolution of epilepsy as a medical condition, indicating a shift towards more contemporary clinical and scientific studies.
  2. Pharmacokinetics of Older Antiepileptic Drugs:
    Research centered on the pharmacokinetics and safety profiles of older anti-seizure medications is less frequent, as newer therapies and their comparative effectiveness take precedence in recent studies.
  3. Epidemiological Studies in Low-Income Regions:
    While still relevant, the volume of epidemiological studies focusing on epilepsy in low-resource settings has decreased, suggesting a potential shift towards more localized or specific clinical studies in developed regions.
  4. Basic Science Research in Animal Models:
    There is a decline in the publication of studies focusing on basic science research using animal models. This may indicate a trend towards translational research that connects laboratory findings more directly with clinical applications.

Similar Journals

Archives of Epilepsy

Illuminating the path to understanding epilepsy.
Publisher: GALENOS PUBL HOUSEISSN: Frequency: 4 issues/year

Archives of Epilepsy is a pioneering academic journal dedicated to advancing the field of epilepsy research and clinical practice. Published by GALENOS PUBL HOUSE in Turkey, this Open Access journal has embraced the principle of unrestricted access since its inception in 2012, allowing researchers, healthcare professionals, and students from around the world to engage with cutting-edge findings in neuropathology. With a focus on clinical and neuroscience aspects of neurology, the journal occupies a significant position in the academic landscape, currently ranked in the Q4 quartile in both Neurology and Clinical Neurology categories as of 2023. Though it faces challenges in its Scopus rankings with a current percentile of 2nd in Medicine - Neurology (Clinical) and 1st in Neuroscience - Neurology, it offers a valuable platform for emerging studies. The journal's commitment to fostering a comprehensive understanding of epilepsy is crucial, as it facilitates broader discourse on effective treatments and patient care strategies. We invite researchers and practitioners to explore the impactful articles published in the Archives of Epilepsy and contribute to an evolving dialogue that strives to improve outcomes for individuals affected by epilepsy.

Acta Epileptologica

Connecting researchers to shape the future of neurology.
Publisher: SPRINGERNATUREISSN: 2096-9384Frequency: 1 issue/year

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.

ACTA NEUROLOGICA BELGICA

Exploring the Depths of Neurological Research.
Publisher: SPRINGER HEIDELBERGISSN: 0300-9009Frequency: 4 issues/year

ACTA NEUROLOGICA BELGICA is a leading academic journal published by Springer Heidelberg, dedicated to advancing the field of neurology and medicine. With an ISSN of 0300-9009 and E-ISSN 2240-2993, this journal has been a vital resource since its inception, contributing significantly to neurological research and clinical practice. It holds a respectable impact factor with categories spanning from Q2 in Medicine (miscellaneous) to Q3 in Neurology (clinical) as of 2023, indicating its prominence in the scientific community. The journal's extensive coverage since 1959 enhances its historical relevance, while its ongoing publication until 2024 ensures the latest developments are readily accessible. Researchers and practitioners can benefit from its rigorous peer-reviewed articles, which are crucial for staying current in this rapidly evolving discipline. As a scholarly platform, ACTA NEUROLOGICA BELGICA plays a pivotal role in disseminating knowledge and fostering innovation in neurology, making it a must-read for professionals, students, and anyone involved in the field.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Enhancing child health outcomes with rigorous scholarship.
Publisher: ELSEVIER SCI LTDISSN: 1090-3798Frequency: 6 issues/year

European Journal of Paediatric Neurology, published by Elsevier Science Ltd, is a premier academic journal dedicated to advancing the field of paediatric neurology. With its ISSN 1090-3798 and E-ISSN 1532-2130, this journal serves as a vital resource for researchers, clinicians, and students alike, focusing on the latest findings and innovative treatments in paediatric neurological disorders. The journal has established itself as a leading publication in its field, achieving a Q1 classification in Pediatrics, Perinatology and Child Health, and holding a reputable Q2 status in Clinical Neurology as of 2023. Positioned within the top 88th percentile in Pediatrics and the 76th percentile in Clinical Neurology according to Scopus ranks, it publishes rigorous peer-reviewed articles that contribute significantly to clinical practice and research. Although not open access, the journal provides vital insights into the complexities of neurological conditions affecting the pediatric population, making it an essential tool for scholars and professionals striving to improve child health outcomes. With a publication trajectory spanning from 1997 to 2024, it continues to be at the forefront of paediatric neurological research, inspiring innovation and collaboration in the scientific community.

EPILEPSY RESEARCH

Connecting researchers to the forefront of epilepsy science.
Publisher: ELSEVIERISSN: 0920-1211Frequency: 10 issues/year

EPILEPSY RESEARCH is a distinguished journal published by Elsevier, focusing on the dynamic field of neurology with a specific emphasis on epilepsy and related neurological disorders. Since its inception in 1987, the journal has become a vital platform for disseminating cutting-edge research, contributing significantly to the understanding of epileptic conditions and their clinical implications. With an impactful presence in the academic community, EPILEPSY RESEARCH currently holds a 2023 Q2 ranking in both the Neurology and Clinical Neurology categories, reflecting its commitment to high-quality, peer-reviewed content. The journal is indexed in SCOPUS, Ranking #173/400 in Clinical Neurology and #91/192 in Neuroscience, ensuring widespread visibility and academic engagement. Although not an open access publication, it provides critical insights, findings, and reviews that are essential for researchers, clinicians, and students alike, fostering advancements in epilepsy research and treatment. For any inquiries, the journal is based at Radarweg 29, 1043 NX Amsterdam, Netherlands.

Annals of Indian Academy of Neurology

Unlocking the Future of Neurology Through Open Access
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0972-2327Frequency: 4 issues/year

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Connecting academia and clinical practice in neurology.
Publisher: W B SAUNDERS CO LTDISSN: 1059-1311Frequency: 10 issues/year

SEIZURE - EUROPEAN JOURNAL OF EPILEPSY is a leading journal published by W B SAUNDERS CO LTD, specializing in the field of epilepsy and seizure disorders. Since its inception in 1992, this journal has committed itself to advancing research and understanding in neurology, achieving a respectable 2023 impact factor reflected by its Q2 rankings in Medicine (miscellaneous), Neurology, and Clinical Neurology categories. With an impressive Scopus ranking that places it in the top 35% of journals in Neuroscience and Neurology, SEIZURE is dedicated to promoting high-quality research and clinical studies that offer insights into epilepsy management and treatment. Although not an open-access journal, it maintains a diverse array of original articles, reviews, and case studies catering to academicians, medical professionals, and students looking to expand their knowledge on epilepsy. This journal is pivotal for those seeking to stay abreast of the latest trends, therapies, and findings in the neuroclinical landscape.

ACTA NEUROLOGICA SCANDINAVICA

Shaping the Future of Neurology and Neuroscience
Publisher: WILEYISSN: 0001-6314Frequency: 12 issues/year

ACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.

Movement Disorders Clinical Practice

Empowering clinicians with cutting-edge research.
Publisher: WILEYISSN: 2330-1619Frequency: 8 issues/year

Movement Disorders Clinical Practice, published by WILEY, is an essential peer-reviewed journal dedicated to advancing the understanding and treatment of movement disorders from a clinical perspective. With an ISSN of 2330-1619, this journal serves as a vital resource for researchers, clinicians, and students engaged in neurology and clinical neuroscience. Since its inception in 2014, the journal has established itself within the medical community, currently positioned in the Q2 category for both Neurology and Neurology (Clinical), reflecting its influence and reputation. Although it does not offer open access, the journal is integral for disseminating high-quality research and clinical insights, thereby contributing significantly to improved patient care and outcomes in the field of movement disorders. Based in Hoboken, NJ, it continues to attract contributions from leading experts and aims to foster a deeper understanding and dialogue surrounding contemporary challenges and advancements in movement disorder treatment.

JOURNAL OF CHILD NEUROLOGY

Innovating Insights for Child Neurology Excellence
Publisher: SAGE PUBLICATIONS INCISSN: 0883-0738Frequency: 14 issues/year

The JOURNAL OF CHILD NEUROLOGY is a distinguished publication in the critical fields of neurology and pediatrics, published by SAGE PUBLICATIONS INC. With its ISSN 0883-0738 and E-ISSN 1708-8283, this journal has been a pivotal resource since its inception in 1986, serving the needs of researchers, clinicians, and students dedicated to advancing the understanding and treatment of neurological disorders in children. As evidenced by its impressive Q2 rankings in both Neurology (clinical) and Pediatrics, Perinatology, and Child Health, the journal has established a reputable position within the academic community, ranking in the 75th percentile for pediatrics and the 53rd percentile for clinical neurology. This periodical not only contributes to the body of knowledge in child neurology but also promotes interdisciplinary collaboration, engaging a global audience through innovative research articles and case studies. Although the journal is not open access, it remains committed to disseminating high-quality research aimed at improving pediatric health outcomes, making it an essential read for professionals and researchers dedicated to this crucial area of medicine.